Search Results

Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the company has completed technical development for its TriVerity™ Acute Infection and Sepsis Test System, which includes the Myrna™ Instrument, and for the TriVerity™ Cartridge.

November 15, 2023

·

3 min read

FDA

Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System

Inflammatix, Inc. announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead product, the TriVerity™ Acute Infection and Sepsis Test System.

November 28, 2023

·

5 min read

Business

Inflammatix Appoints Heiner Dreismann as New Board Member

Inflammatix, a pioneering molecular diagnostics company, announced the appointment of Heiner Dreismann, PhD, as a member of the company’s board of directors.

July 10, 2023

·

2 min read

Business

Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer

Inflammatix, Inc., a pioneering molecular diagnostics company, announced today the appointment of Purvesh Khatri, PhD, as Chief Scientific Officer.

June 15, 2022

·

2 min read

Business

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member

Inflammatix announced today the appointment of Kian Beyzavi, PhD, as an independent member of the company’s board of directors.

November 30, 2021

·

2 min read

Biotech Bay

Inflammatix Awarded $1.7 Million Grant From National Institutes of Health (NIH)

Inflammatix has awarded the company a Small Business Innovation Research (NIH SBIR) Direct-to-Phase II grant of $1.7 million.

November 11, 2021

·

3 min read